GlassScriptPhysician profile
Sarah Ames
NPI 1194445452
$1,067.88
in general payments reported to CMS, 2019-2025
23 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $75.08 · 2024: $695 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040 · Education: $27.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.36 |
| Education | $27.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $175.39 | 2024-2025 | Wegovy, Saxenda |
| Abbvie INC. | $168.58 | 2023-2025 | |
| Medtronic, INC. | $80.61 | 2024 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $75.13 | 2024-2025 | Airsupra, Farxiga |
| Pfizer INC. | $68.22 | 2024-2025 | |
| Dexcom, INC. | $56.72 | 2023-2025 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $40.09 | 2024 | Dupixent |
| Madrigal Pharmaceuticals | $39.29 | 2024-2025 | Rezdiffra, Resmetirom |
| Glaxosmithkline, LLC. | $34.46 | 2024 | Trelegy Ellipta |
| Antares Pharma, INC. | $34.11 | 2024-2025 | Xyosted |
| Exact Sciences Corporation | $31.43 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Indivior INC. | $31.33 | 2024 | Sublocade |
| E.R. Squibb & Sons, L.L.C. | $29.05 | 2024-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $28.08 | 2024 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $27.52 | 2025 | Eohilia |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $27.16 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Otsuka America Pharmaceutical, INC. | $24.23 | 2025 | Rexulti |
| Boston Scientific Corporation | $19.05 | 2023 | |
| Halozyme INC | $16.86 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.45 | 2025 | |
| Axsome Therapeutics, INC. | $16.03 | 2024 | Auvelity |
| Heartflow, INC. | $15.31 | 2024 | |
| Organon LLC | $12.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Ames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.